This report contains market size and forecasts of Coronary Intervention Drug Eluting Stent in global, including the following market information:
Global Coronary Intervention Drug Eluting Stent Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Coronary Intervention Drug Eluting Stent Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Coronary Intervention Drug Eluting Stent companies in 2021 (%)
The global Coronary Intervention Drug Eluting Stent market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Below 40 µm Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Coronary Intervention Drug Eluting Stent include Synlas GmbH, YILSON, BrosMed Medical, SCITECH Medical, Wellinq, Degania Silicone, Alvimedica, Interventional Medical Device Solutions and Comed BV, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Coronary Intervention Drug Eluting Stent manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Coronary Intervention Drug Eluting Stent Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Coronary Intervention Drug Eluting Stent Market Segment Percentages, by Type, 2021 (%)
Below 40 µm
40 µm- 65 µm
Above 65 µm
Global Coronary Intervention Drug Eluting Stent Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Coronary Intervention Drug Eluting Stent Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Others
Global Coronary Intervention Drug Eluting Stent Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Coronary Intervention Drug Eluting Stent Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Coronary Intervention Drug Eluting Stent revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Coronary Intervention Drug Eluting Stent revenues share in global market, 2021 (%)
Key companies Coronary Intervention Drug Eluting Stent sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Coronary Intervention Drug Eluting Stent sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Synlas GmbH
YILSON
BrosMed Medical
SCITECH Medical
Wellinq
Degania Silicone
Alvimedica
Interventional Medical Device Solutions
Comed BV
iVascular
LEPU Medical
Eurocor Tech GmbH
OrbusNeich
Endocor GmbH
Meril Life Sciences
Acrostak
Boston Scientific Corporation
B. Braun
Biotronik
Abbott
MicroPort Medical Group
Philips
Terumo Corporation